Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Pediatric Rheumatology Online Journal|October 24, 2018
Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritisJennifer C Cooper, Kelly Rouster-Stevens, Tracey B Wright, et al.
Human Molecular Genetics|January 30, 2022
Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositisClaire T Deakin, John Bowes, Lisa G Rider, et al.
ACR Open Rheumatology|November 26, 2025
Characteristics Associated With EuroLupus Versus Modified National Institutes of Health Cyclophosphamide Regimen Use in Children and Young Adults With Lupus NephritisChristine S Wang, Rebecca E Sadun, Wenru Zhou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 6, 2023
Renal Response Outcomes of the EuroLupus and National Institutes of Health Cyclophosphamide Dosing Regimens in Childhood-Onset Proliferative Lupus NephritisChristine S Wang, Rebecca E Sadun, Wenru Zhou, et al.
Arthritis and Rheumatism|March 2, 2013
Susceptibility to childhood-onset rheumatoid arthritis: investigation of a weighted genetic risk score that integrates cumulative effects of variants at five genetic lociSampath Prahalad, Karen N Conneely, Yunxuan Jiang, et al.
Annals of the Rheumatic Diseases|April 8, 2017
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeLisa G Rider, Rohit Aggarwal, Angela Pistorio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 7, 2017
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeLisa G Rider, Rohit Aggarwal, Angela Pistorio, et al.
Arthritis Care & Research|October 22, 2014
Novel method to collect medication adverse events in juvenile arthritis: results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance projectSarah Ringold, Audrey Hendrickson, Leslie Abramson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2021
International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus NephritisNathalie E Chalhoub, Scott E Wenderfer, Deborah M Levy, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 13, 2024
Interleukin (IL)-1/IL-6-Inhibitor-Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory IllnessesVivian E Saper, Lu Tian, Ruud H J Verstegen, et al.
Pageof 4